Association Between Consumption of Ultraprocessed Foods and Cognitive Decline

Carregando...
Imagem de Miniatura
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER MEDICAL ASSOC
Autores
KHANDPUR, Neha
STEELE, Euridice Martinez
CARAMELLI, Paulo
MATOS, Sheila Maria Alvim de
MARCHIONI, Dirce M.
Citação
JAMA NEUROLOGY, v.80, n.2, p.142-150, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Importance Although consumption of ultraprocessed food has been linked to higher risk of cardiovascular disease, metabolic syndrome, and obesity, little is known about the association of consumption of ultraprocessed foods with cognitive decline.Objective To investigate the association between ultraprocessed food consumption and cognitive decline in the Brazilian Longitudinal Study of Adult Health.Design, Setting, and Participants This was a multicenter, prospective cohort study with 3 waves, approximately 4 years apart, from 2008 to 2017. Data were analyzed from December 2021 to May 2022. Participants were public servants aged 35 to 74 years old recruited in 6 Brazilian cities. Participants who, at baseline, had incomplete food frequency questionnaire, cognitive, or covariate data were excluded. Participants who reported extreme calorie intake (6000 kcal/day) and those taking medication that could negatively interfere with cognitive performance were also excluded.Exposures Daily ultraprocessed food consumption as a percentage of total energy divided into quartiles.Main Outcomes and MeasuresChanges in cognitive performance over time evaluated by the immediate and delayed word recall, word recognition, phonemic and semantic verbal fluency tests, and Trail-Making Test B version.Results A total of 15 105 individuals were recruited and 4330 were excluded, leaving 10 775 participants whose data were analyzed. The mean (SD) age at the baseline was 51.6 (8.9) years, 5880 participants (54.6%) were women, 5723 (53.1%) were White, and 6106 (56.6%) had at least a college degree. During a median (range) follow-up of 8 (6-10) years, individuals with ultraprocessed food consumption above the first quartile showed a 28% faster rate of global cognitive decline (beta = -0.004; 95% CI, -0.006 to -0.001; P = .003) and a 25% faster rate of executive function decline (beta = -0.003, 95% CI, -0.005 to 0.000; P = .01) compared with those in the first quartile.Conclusions and Relevance A higher percentage of daily energy consumption of ultraprocessed foods was associated with cognitive decline among adults from an ethnically diverse sample. These findings support current public health recommendations on limiting ultraprocessed food consumption because of their potential harm to cognitive function.
Palavras-chave
Referências
  1. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  2. Bagetta D, 2020, EUR J MED CHEM, V186, DOI 10.1016/j.ejmech.2019.111903
  3. Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2
  4. Beilharz JE, 2014, BRAIN BEHAV IMMUN, V37, P134, DOI 10.1016/j.bbi.2013.11.016
  5. Berti V, 2015, J NUTR HEALTH AGING, V19, P413, DOI 10.1007/s12603-014-0534-0
  6. Bertolucci PHF., 1998, ARCH CLIN PSYCHIAT
  7. Bolker B., 2021, LME4
  8. Calice-Silva V, 2021, ALZ DIS ASSOC DIS, V35, P128, DOI 10.1097/WAD.0000000000000431
  9. Canhada SL, 2020, PUBLIC HEALTH NUTR, V23, P1076, DOI 10.1017/S1368980019002854
  10. Cardoso BR, 2022, EUR J NUTR, V61, P3975, DOI 10.1007/s00394-022-02911-1
  11. Chiesa ST, 2019, EUR HEART J, V40, P2300, DOI 10.1093/eurheartj/ehz189
  12. Clarke R, 1999, AM J EPIDEMIOL, V150, P341
  13. de Miranda RC, 2021, CURR OPIN LIPIDOL, V32, P24, DOI 10.1097/MOL.0000000000000728
  14. Croll PH, 2018, NEUROLOGY, V90, pE2166, DOI [10.1212/WNL.0000000000005691, 10.1212/wnl.0000000000005691]
  15. Louzada MLD, 2015, PREV MED, V81, P9, DOI 10.1016/j.ypmed.2015.07.018
  16. Mendonca RD, 2016, AM J CLIN NUTR, V104, P1433, DOI 10.3945/ajcn.116.135004
  17. Ekstrand B, 2021, NUTR REV, V79, P693, DOI 10.1093/nutrit/nuaa091
  18. Engels JM, 2003, J CLIN EPIDEMIOL, V56, P968, DOI 10.1016/S0895-4356(03)00170-7
  19. Feldman HH, 2014, ANN NY ACAD SCI, V1313, P1, DOI 10.1111/nyas.12424
  20. Fiolet T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k322
  21. GBD 2019 Dementia Forecasting Collaborators, 2022, Lancet Public Health, V7, pe105, DOI 10.1016/S2468-2667(21)00249-8
  22. Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979
  23. GREENLIEF CL, 1985, PERCEPT MOTOR SKILL, V61, P1283, DOI 10.2466/pms.1985.61.3f.1283
  24. Gu Y, 2015, NEUROLOGY, V85, P1744, DOI 10.1212/WNL.0000000000002121
  25. Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496
  26. Jacka FN, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0461-x
  27. Jokinen H, 2006, J NEUROL NEUROSUR PS, V77, P28, DOI 10.1136/jnnp.2005.069120
  28. Kim H, 2019, PUBLIC HEALTH NUTR, V22, P1777, DOI [10.1017/s1368980018003890, 10.1017/S1368980018003890]
  29. Li HP, 2022, NEUROLOGY, V99, pE1056, DOI 10.1212/WNL.0000000000200871
  30. Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6
  31. Molina M.D.C.B., 2013, CADERNOS SA DEP BLIC, V29, P379, DOI 10.1590/S0102-311X2013000200024
  32. Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762
  33. MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457
  34. Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1015, DOI 10.1016/j.jalz.2015.04.011
  35. Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P1849, DOI 10.1001/archneur.62.12.noc50161
  36. Moubarac JC, 2017, APPETITE, V108, P512, DOI 10.1016/j.appet.2016.11.006
  37. Pagliai G, 2021, BRIT J NUTR, V125, P308, DOI 10.1017/S0007114520002688
  38. Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
  39. Prince M., 2014, DEMENTIA RISK REDUCT
  40. R Core Team, 2018, R LANG ENV STAT COMP
  41. Rauber F, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027546
  42. Rico-Campa A, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1949
  43. Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P216, DOI 10.1001/archneurol.2008.536
  44. Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854
  45. Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
  46. Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x
  47. Shen W, 2014, J NUTR, V144, P1181, DOI 10.3945/jn.114.194332
  48. Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003
  49. Srour B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1451
  50. Steele EM, 2019, PREV MED, V125, P40, DOI 10.1016/j.ypmed.2019.05.004
  51. Steele EM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009892
  52. Strauss E, 2006, COMPENDIUM NEUROPSYC, V3rd
  53. Weinstein G, 2023, J GERONTOL A-BIOL, V78, P134, DOI 10.1093/gerona/glac070
  54. Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861
  55. WHO, RISK RED COGN DECL D
  56. Willett W., 2013, NUTR EPIDEMIOLOGY
  57. World Health Organization, 2012, World Health Organ Tech Rep Ser, P1
  58. World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053